Elicio Therapeutics, Inc. Contract Liability (Deferred Revenue)
Elicio Therapeutics, Inc. (ELTX) had Contract Liability (Deferred Revenue) of $0 as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-03-12
- 2025-12-31: Contract with Customer, Liability, Current $0.00.
- 2025-09-30: Contract with Customer, Liability, Current $0.00.
- 2025-06-30: Contract with Customer, Liability, Current $0.00.
- 2025-03-31: Contract with Customer, Liability, Current $680.00K.
| Period end | Contract with Customer, Liability, Current | Contract with Customer, Liability, Current as first filed |
|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $680.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $1.17M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $1.31M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $350.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $627.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $694.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.66M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |
| 2022-12-31 | $1.44M 10-K · filed 2024-03-29 | $0.00 10-K · filed 2023-03-17 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $653.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $2.30M 10-K · filed 2023-03-17 | |
| 2021-09-30 | $3.66M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $5.18M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.79M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $3.94M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |